Study of Acid Peel and Laser for the Treatment of Melasma

This study is currently recruiting participants.

Verified by Northwestern University, October 2008

Sponsored by:	Northwestern University
Information provided by:	Northwestern University
ClinicalTrials.gov Identifier:	NCT00467233

Purpose

The objective of this study is to evaluate laser treatment and acid peel for the treatment of melasma.

Condition	Intervention
Melasma	Procedure: Laser Treatment Procedure: Acid Peel

Study Type:	Interventional
Study Design:	Treatment, Randomized, Single Blind (Outcomes Assessor), Active Control, Single Group Assignment, Safety/Efficacy Study
Official Title:	Study of Acid Peel and Laser for the Treatment of Melasma

Further study details as provided by Northwestern University:

Primary Outcome Measures:

Secondary Outcome Measures:

Estimated Enrollment:	20
Study Start Date:	May 2007
Estimated Study Completion Date:	December 2008
Estimated Primary Completion Date:	December 2008 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
1: Experimental Laser Treatment	Procedure: Laser Treatment Laser treatment to half of the face at each study visit
2: Experimental Acid peel	Procedure: Acid Peel Acid peel to half of the face at each study visit

Detailed Description:

The purpose of this study is to evaluate the safety and efficacy of laser treatment and acid peel for the treatment of melasma.

Eligibility

Criteria

Inclusion Criteria:

Diagnosis of melasma lesion measuring at least 4 square centimeters.
Age 18-75 years.
Good health.
Willingness and ability to understand and provide informed consent for participation in the study.
Ability to communicate with the investigator.
Must be willing to forgo other treatment options for melasma during the course of the study.

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00467233

Contacts

Contact: Natalie Kim

312 695 6785

Locations

United States, Illinois
Northwestern University Dermatology Department	Recruiting
Chicago, Illinois, United States, 60611
Principal Investigator: Murad Alam, MD
Sub-Investigator: Alfred Rademaker, PhD
Sub-Investigator: Mary Martini, MD
Sub-Investigator: Natalie Kim

Sponsors and Collaborators

Northwestern University

Investigators

Principal Investigator:

Murad Alam, MD

Northwestern University

More Information

Responsible Party:	Murad Alam, MD ( Northwestern University )
Study ID Numbers:	MA-123456-DD
Study First Received:	April 26, 2007
Last Updated:	October 2, 2008
ClinicalTrials.gov Identifier:	NCT00467233
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Hyperpigmentation
Skin Diseases
Pigmentation Disorders
Melanosis

ClinicalTrials.gov processed this record on January 15, 2009